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1023lthough the first percutaneous transradial approach
TRA) for diagnostic coronary angiography was de-
cribed by Dr. Lucien Campeau in 1989 and for inter-
ention by Dr. Ferdinand Kiemeneij in 1993, its practice
as remained somewhat limited to countries outside the
.S. (1–3). Until recently, it remained vigorously pro-
oted by a dedicated group of operators and disregarded
y a large number of operators traditionally trained in the
emoral approach (FA) (4,5).
See page 1032
The direct impact of peri-procedural bleeding and
ccess-site complications on outcomes and costs to health
ystems has initiated an increasing awareness of the
otential benefits for TRA as a default technique instead
f the FA (6 –9). Even in the U.S., a recent study has
ound a significant increase in the use of TRA for
ercutaneous coronary interventions (PCI); however, its
se remains low (5%) (10).
There currently are no data on the worldwide penetra-
ion of TRA and its associated strategies, such as choice
f right or left radial artery, diagnostic and interventional
uide catheters, selection of antithrombotic therapy, and
o forth. Because the practice of TRA will likely continue
o increase in the coming years, we thought to evaluate its
ractice around the world. With an Internet-based ques-
ionnaire, we surveyed interventional cardiologists to
etter understand their TRA practice regarding patient
election, technical aspects for diagnostic use and inter-
entions, antithrombotic regimens, access-site manage-
ent, and hospital discharge.
ethods
e designed a dedicated questionnaire including 39
uestions covering: 1) respondent characteristics; 2) pa-
ient selection; 3) technical aspects of access site puncture
nd hemostasis; 4) technical aspects of diagnostic angiog-
aphy and interventions; 5) antithrombotic regimens used
n elective PCI and acute coronary syndrome (ACS)
ases; 6) radial artery occlusion (RAO) after PCI; and 7)
ospital discharge after PCI.
We used Internet-based software (SurveyMonkey,
enlo Park, California) to carry out our survey. To
nsure that questions were easy to understand and cov-
red the majority of TRA-related topics and that the
urvey could be completed in approximately 10 min, we
ent the survey first to a group of 15 selected interven-
ional cardiologists with extensive experience with TRA.
inor corrections were applied, and the survey was
fficially launched on the Internet on August 27, 2009. pOur objective was to collect at least 1,000 responses
rom around the world. To maximize response rate, we
ontacted national working groups in interventional car-
iology, official societies such as the Canadian Associa-
ion of Interventional Cardiology and the Society for
ardiovascular Angiography and Interventions, and we
lso sent personalized invitation e-mails to interventional
ardiologists found after PubMed search. To ensure
rivacy and consistency, the identity of respondents
emained unknown, and each respondent could answer
he questionnaire only once. The software allows moni-
oring results at all times as well as downloading results in
spreadsheet anytime. Data are descriptive. Values are
eported as percentages of the total number of responses.
esults
emographic data and baseline
haracteristics. Responses were
ollected from August 27, 2009
o January 29, 2010. At this
ime, 1,107 interventional car-
iologists had taken the ques-
ionnaire, and 874 (79%) had
nswered all questions. The re-
ponse rate/question varied from
7% to 100%. Respondents were
rom 75 countries (Fig. 1). The
op 5 countries were Canada
n  107, 9.7%), Italy (n  97,
.8%), Japan (n  95, 8.6%),
.S. (n  87, 7.8%), and Spain
n  72, 6.5%). Most respon-
ents (65.6%) were older than
0 years, and 92.9% were men
Table 1). All age categories
rom 30 years (2.3%) to 60
ears (4.2%) were represented, with 39.7% of respondents
etween 40 and 50 years of age. Respondents using TRA
or diagnostic catheterization were either low-volume
5%  15.4% of respondents) or very high-volume
90%  42.4%) TRA operators. Still, high-volume
RA (90%) operators use that approach less frequently
or PCI (32.1%) than for diagnostic purposes (42.4%).
his gap existed in all countries but is even larger in
hina, India, and Japan. The large majority of respon-
ents using TRA are moderate- or high-volume opera-
ors, performing 100 PCIs/year.
ccess-site selection and technical aspects. The large
ajority (89.4%) of operators use the right radial artery as
he initial side, although in Japan, 16.8% prefer the left
ide (Table 2). Although 58.1% of respondents use the
llen test, and 16.4% use the more objective oximetry/
Abbreviations
and Acronyms
ACS  acute coronary
syndrome
Cx  circumflex artery
FA  femoral approach
GPI  glycoprotein IIb/IIIa
receptor inhibitors
LAD  left anterior
descending artery
LCA  left coronary artery
PCI  percutaneous
coronary intervention
RAO  radial artery
occlusion
RCA  right coronary artery
TRA  transradial approachlethysmography test (39.5% in the U.S.), it should be
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1024oted that 23.4% still do not assess dual hand circulation
efore procedure. Interestingly, 31.3% cross over to the
ontralateral radial artery after initial radial access failure,
hereas most (54.5%) revert to the standard FA. In Japan
reater than one-third of operators attempt the homo-
ateral brachial artery in case of initial radial artery access
ailure. Interestingly, after initial radial access site failure,
ontralateral TRA or FA will be used in 41.0% and 47.1%
f operators that use TRA in 50% of their PCI
rocedures compared with 15.7% and 66.5%, respec-
ively, in operators that use TRA in 50% of their PCI
rocedures.
Before entry of the patient in the catheterization suite,
1.7% of respondents prescribe anxiety relievers, 10.2%
Figure 1. Participating Countries
1,107 participants from 75 different countries answered the survey.se antihistaminic drugs, and 12.5% use local Xylocaine Hpray or gel, but 45.7% do not use any medication (Table 2).
he large majority of operators use vasodilators to
revent radial artery spasm; however, 14.1% of operators,
specially in Japan, do not use any vasodilators.
For radial artery puncture, most in the U.S., Canada,
nd Europe use a bare needle, whereas in China, India,
nd Japan, operators prefer a sheath-covered needle. The
heath length is most frequently short (52.3% use 10 cm)
r very short (34.7% use 7.5 cm), and few operators use
onger sheaths, except in Japan. The large majority of
perators prefer using hydrophilic sheaths (69.8%) com-
ared with non-hydrophilic sheaths. After radial punc-
ure, preference is now toward smaller-size introducing
ire either 0.025 inch (43.5%) or 0.025 inch (31.4%).
owever, to advance catheters through the arm up to the
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1025oronary ostia, standard J-shaped 0.035-inch (0.889-
m) wire remains the most frequently used wire (80.0%).
n case of radial or brachial artery tortuosity or loops,
ost operators (74.7%) use hydrophilic wire (Glidewire,
erumo, Tokyo, Japan) or even 0.014-inch (0.356-mm)
oronary wires (10.1%) in case of severe anatomical
ifficulties. For diagnostic angiography, although 4- or
-F sheath sizes are used in 50% of the cases in the U.S.
nd Japan, 6-F size remains standard in Canada, Europe,
nd China (Table 2).
ntithrombotic strategies for TRA. Most operators use
eparin to prevent RAO (75.8% use 2,000 to 5,000 IU
eparin), but approximately 5% do not use any heparin
Fig. 2A). In case of elective and uncomplicated PCI
ases, most operators outside the U.S. use 70 to 100
U/kg heparin, whereas bivalirudin (53.2%) is frequently
sed in the U.S. (Fig. 2B). After aspirin and clopidogrel-
oading for the treatment of ACS, heparin only (37.9%)
r heparin  glycoprotein IIb/IIIa receptor inhibitor
GPI) (46.7%) remains the most frequently used routine
Table 1. Demographic Data
All U.S. Canada-Europe China India Japan
Age (yrs)
30 2.3 1.1 1.9 9.1 0.0 1.1
30–40 32.1 29.9 31.6 45.5 37.8 36.8
40–50 39.7 31.0 37.4 38.6 35.1 50.5
50–60 21.7 29.9 24.0 6.8 27.0 11.6
60 4.2 8.0 5.1 0.0 0.0 0.0
Male 92.9 95.4 92.0 95.5 100.0 93.7
Use of TRA in diagnostic
5 15.4 28.7 14.7 0.0 13.5 4.2
5–25 12.1 17.2 13.1 2.3 5.4 0.0
25–50 6.6 13.8 7.4 4.5 2.7 0.0
50–75 8.7 11.5 8.9 15.9 2.7 3.2
75–90 14.8 12.6 14.7 9.1 10.8 24.2
90 42.4 16.1 41.2 68.2 64.9 68.4
Use of TRA in PCI
5 19.0 36.8 17.6 2.3 16.2 1.1
5–25 9.9 13.8 10.9 4.5 8.1 2.1
25–50 9.1 9.2 9.3 9.1 5.4 6.3
50–75 9.6 12.6 7.7 13.6 8.1 18.9
75–90 20.3 12.6 21.5 22.7 10.8 34.7
90 32.1 14.9 32.9 47.7 51.4 36.8
PCI cases annually
100 12.8 16.1 8.0 20.5 13.5 29.5
100–300 52.7 59.8 53.3 31.8 56.8 50.5
300 34.5 24.1 38.7 47.7 29.7 20.0
Values given are percentages. Canada-Europe stands for: Italy, Spain, Germany, Poland, France,
United Kingdom, Belgium, Turkey, Norway, Lithuania, Czech Republic, Switzerland, Bulgaria,
Hungary, Denmark, Russian Federation, Sweden, the Netherlands, Armenia, Ukraine, Latvia,
Former Yugoslav Republic ofMacedonia, Greece, Croatia, Albania, Ireland, Finland, Canada, Israel,
Austria, Belarus, Kazakhstan, Luxembourg, Malta, and Romania.
PCI percutaneous coronary intervention; TRA transradial approach.ith little use of bivalirudin (7.4%) outside the U.S. InTable 2. Access-Site Selection and Technical Aspects
All U.S. Canada-Europe China India Japan
Preferred side for TRA
Right radial 89.4 92.0 89.5 93.2 94.6 83.2
Left radial 10.6 8.0 10.5 6.8 5.4 16.8
Test to assess dual hand
circulation before TRA
Allen 58.1 46.1 57.2 81.4 50.0 60.0
Oximetry/plethysmography 16.4 39.5 15.5 2.3 31.3 1.1
No testing 23.4 7.9 25.5 16.3 18.8 36.7
Other 2.1 6.6 1.8 0.0 0.0 2.2
If radial access fails, next choice
Homolateral brachial 10.4 9.2 6.7 9.1 0.0 35.8
Contralateral radial 31.3 25.3 33.9 31.8 21.6 36.8
Homolateral ulnar 3.3 3.4 3.2 9.1 2.7 0.0
Contralateral ulnar 0.5 0.0 0.3 4.5 0.0 2.1
Femoral 54.5 62.1 55.9 45.5 75.7 25.3
Pre-medication
None 45.7 51.7 45.6 43.2 43.2 49.5
Anxiety relievers 41.7 46.0 45.3 27.3 29.7 21.1
Anti-allergy 10.2 16.1 9.0 25.0 21.6 1.1
Local Xylocaine 12.5 2.3 11.8 11.4 10.8 27.4
Anti-ulcer 3.1 5.7 1.7 13.6 16.2 3.2
Other 5.7 5.7 4.5 4.5 2.7 6.3
Needle radial puncture
Bare needle 59.6 73.5 70.2 35.3 20.6 2.2
Sheath-covered needle 40.4 26.5 29.8 64.7 79.4 97.8
Sheath length (cm)
7.5 34.7 32.5 37.6 23.5 76.5 8.9
10 52.3 53.0 53.2 50.0 23.5 45.6
20 13.0 14.5 9.2 26.5 0.0 45.6
Type of sheath
Hydrophilic 69.8 88.0 62.6 76.5 85.3 88.9
Nonhydrophilic 30.2 12.0 37.4 23.5 14.7 11.1
To prevent radial artery spasm
NTG and verapamil 31.0 53.0 31.2 32.4 38.2 1.1
NTG, verapamil, Xylocaine 6.6 8.4 5.1 17.6 14.7 1.1
NTG only 17.1 13.3 17.9 32.4 2.9 21.1
Verapamil only 27.1 14.5 33.2 2.9 17.6 2.2
No medication 14.1 2.4 9.7 11.8 0.0 72.2
Other 4.2 8.4 2.8 2.9 26.5 2.2
Introducing wire (inches)
0.025 31.4 50.6 31.4 11.8 14.7 27.8
0.025 43.5 38.6 44.9 29.4 55.9 51.1
0.032 10.3 2.4 10.1 32.4 5.9 5.6
0.035 14.7 8.4 13.6 26.5 23.5 15.6
Sheath size, diagnostic (F)
4 12.0 13.3 5.6 2.9 0.0 76.7
5 41.6 50.6 40.7 29.4 91.2 23.3
6 45.7 34.9 53.0 67.6 8.8 0.0
Sheathless 0.7 1.2 0.6 0.0 0.0 0.0
Advancing wire (inches)
0.035 J-shaped standard 80.0 80.7 88.5 44.1 67.6 35.6
0.035 soft 3.1 12.0 1.9 5.9 0.0 4.4
Hydrophilic 16.9 7.2 9.7 50.0 32.4 60.0
Wire if tortuosity or loop
(inches)
0.014 10.1 13.3 10.5 11.8 23.5 1.1
0.035 J-shaped standard 8.5 2.4 7.3 2.9 0.0 26.7
0.035 soft 4.1 13.3 2.0 8.8 0.0 4.4
Hydrophilic 74.7 69.9 78.2 76.5 73.5 56.7
Other 2.6 1.2 2.0 0.0 2.9 11.1
Values given are percentages.NTG nitroglycerin; other abbreviations as in Table 1.
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1026he U.S., heparin  GPI (41.8%) or bivalirudin  GPI
39.2%) are the most frequent antithrombotic strategies
n ACS (Fig. 2C).
hoice of coronary catheters for diagnostic TRA procedures.
or angiography of the left coronary artery (LCA) and
Figure 2. Heparin Dose to Prevent RAO, and Antithrombotic Therapies for
Elective and Uncomplicated PCI and for ACS
Heparin dose routinely used to prevent radial artery occlusion (RAO) (A),
and antithrombotic therapies used for elective and uncomplicated percuta-
neous coronary intervention (PCI) (B) and for acute coronary syndrome
(ACS) (C). Can-Euro  Canada and Europe; GPI  glycoprotein IIb/IIIa inhib-
itor; LMWH  low molecular weight heparin.ight coronary artery (RCA), the Judkins left 3.5 (44.9%)r 4.0 (21.6%) for LCA and Judkins right 4.0 (58.8%)
or RCA remain the most commonly used catheters
Table 3). Few operators still use first-generation dedi-
ated single catheters for LCA and RCA angiography,
lthough multipurpose catheters are used in China and
he recently developed Tiger II (Terumo) catheters are
opular in India. For angiography of left or right bypass
rafts, Judkins right remains the most frequently used
atheter shape— 48.6% and 46.8%, respectively. Not
Table 3. Diagnostic Catheters
All U.S. Canada-Europe China India Japan
LCA
Judkins left 3.5 44.9 37.8 49.4 25.8 15.2 26.4
Judkins left 4.0 21.6 14.6 23.1 12.9 0.0 35.6
Kimny 1.8 7.3 1.1 3.2 3.0 2.3
Multipurpose 6.2 4.9 4.3 45.2 0.0 11.5
Tiger/Tiger II 16.1 12.2 15.1 12.9 75.8 1.1
Amplatz left 2.2 1.2 2.9 0.0 0.0 1.1
Barbeau 0.2 0.0 0.3 0.0 0.0 0.0
Fajadet left 0.1 0.0 0.0 0.0 0.0 0.0
Other 7.0 22.0 3.8 0.0 6.1 21.8
RCA
Judkins right 4.0 58.8 46.3 64.6 38.7 12.1 52.9
Kimny 1.7 7.3 1.0 3.2 3.0 2.3
Multipurpose 6.7 7.3 4.6 45.2 0.0 11.5
Tiger/Tiger II 14.9 11.0 14.4 9.7 66.7 1.1
Amplatz left 2.4 2.4 2.9 0.0 0.0 1.1
Amplatz right 2.2 3.7 2.9 0.0 0.0 0.0
Barbeau 0.5 0.0 0.8 0.0 0.0 0.0
Fajadet right 0.1 0.0 0.0 0.0 0.0 0.0
Other 12.7 22.0 8.8 3.2 18.2 31.0
SVG to LCA
Judkins right 48.6 41.5 51.6 41.9 27.3 40.2
Left bypass 11.5 6.1 11.7 16.1 3.0 3.4
Amplatz left 22.6 26.8 23.4 12.9 18.2 36.8
Multipurpose 7.3 7.3 5.6 19.4 21.2 5.7
Tiger/Tiger II 3.9 6.1 3.4 9.7 6.1 0.0
Kimny 0.7 1.2 0.8 0.0 0.0 0.0
Barbeau 0.1 0.0 0.2 0.0 0.0 0.0
Fajadet 0.1 0.0 0.0 0.0 0.0 0.0
Other 5.3 11.0 3.4 0.0 24.2 13.8
SVG to RCA
Judkins right 46.8 25.6 48.1 41.9 39.4 43.7
Right bypass 8.0 3.7 8.5 6.5 3.0 3.4
Amplatz left 12.0 7.3 10.3 25.8 18.2 34.5
Multipurpose 23.8 53.7 25.2 16.1 12.1 4.6
Tiger/Tiger II 3.1 2.4 2.9 6.5 3.0 0.0
Kimny 0.4 0.0 0.5 0.0 0.0 1.1
Barbeau 0.4 0.0 0.6 0.0 0.0 0.0
Fajadet 0.0 0.0 0.0 0.0 0.0 0.0
Other 5.6 7.3 4.0 3.2 24.2 12.6
Values given are percentages.LCA left coronary artery; RCA right coronary artery; SVG saphenous vein graft.
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1027urprisingly, left bypass (11.5%) or Amplatz left (22.6%)
atheters for left bypass grafts and Amplatz left (12.0%)
r multipurpose (23.8%) catheters for right bypass grafts
re also frequently used.
hoice of coronary guide catheters for PCI via TRA. For
CI of LCA and RCA, the large majority of operators
refer to use 6-F catheter size (Figs. 3A and 3B). Only
pproximately 10% of operators use 5-F guiding catheters
or RCA PCI, and 10% use 5-F guiding catheters for
CA PCI in 50% of cases. For left anterior descending
LAD) and circumflex (Cx) coronary artery lesions,
perators routinely use standard extra back-up guiding
atheters, the most popular being the EBU 3.5 (Med-
ronic, Minneapolis, Minnesota)—27.9% for LAD and
6.1% for Cx arteries (Table 4). Interestingly, a signifi-
ant number of operators still use guiding catheters
ffering less support, such as Judkins left in 22.5% for
AD lesions and in 12.5% for Cx lesions. Similarly, the
ost popular guiding catheter shape for RCA lesions
emains the Judkins right in 70.2% of cases. For left
ypass graft PCI, Amplatz left (37.3%), Judkins right
Figure 3. Guiding Catheters Sizes for PCI of RCA and LCA
Guiding catheters sizes for PCI of right coronary artery (RCA) (A) and left
coronary artery (LCA) (B). Abbreviations as in Figure 2.31.0%), and left bypass graft (19.4%) guiding cathetersTable 4. PCI-Guiding Catheters
All U.S. Canada-Europe China India Japan
LAD
Judkins left 22.5 6.3 21.6 20.7 10.0 38.4
XB 3.0 8.1 10.1 7.0 20.7 16.7 0.0
XB 3.5 18.2 26.6 18.9 13.8 6.7 5.8
Amplatz left 1.4 2.5 1.3 0.0 3.3 0.0
Tiger II 0.6 1.3 0.5 0.0 3.3 0.0
EBU 3.5 27.9 35.4 26.9 41.4 50.0 20.9
EBU 3.75 6.5 7.6 7.9 3.4 3.3 5.8
EBU 4.0 5.6 1.3 8.0 0.0 0.0 2.3
Kimny 0.8 2.5 0.8 0.0 0.0 0.0
Fajadet left 0.5 1.3 0.5 0.0 0.0 0.0
MUTA left 0.7 0.0 1.1 0.0 0.0 0.0
Other 7.1 5.1 5.4 0.0 6.7 26.7
Cx
Judkins left 12.5 5.1 11.0 3.4 0.0 26.7
XB 3.0 6.5 6.3 4.9 13.8 13.3 1.2
XB 3.5 20.8 30.4 21.3 17.2 20.0 8.1
Amplatz left 10.8 3.8 13.0 10.3 6.7 5.8
Tiger II 0.3 0.0 0.3 0.0 3.3 0.0
EBU 3.5 26.1 26.6 25.1 48.3 43.3 25.6
EBU 3.75 6.2 15.2 6.1 3.4 6.7 7.0
EBU 4.0 8.7 2.5 11.8 0.0 3.3 3.5
Kimny 0.8 1.3 1.0 0.0 0.0 0.0
Fajadet left 0.5 2.5 0.2 3.4 0.0 0.0
MUTA left 0.4 0.0 0.7 0.0 0.0 0.0
Other 6.3 6.3 4.8 0.0 3.3 22.1
RCA
Judkins right 70.2 69.6 70.3 93.1 80.0 48.8
Amplatz right 10.2 11.4 12.0 0.0 6.7 2.3
Amplatz left 5.8 7.6 5.4 0.0 6.7 10.5
Barbeau 1.9 1.3 2.6 3.4 0.0 0.0
Kimny 1.3 3.8 1.3 0.0 0.0 0.0
Fajadet right 0.4 0.0 0.5 0.0 0.0 0.0
MUTA right 0.2 0.0 0.3 0.0 0.0 0.0
Other 9.8 6.3 7.5 3.4 6.7 38.4
Left SVG
Left bypass graft 19.4 16.5 21.0 24.1 3.3 7.0
Amplatz left 37.3 39.2 36.6 24.1 26.7 62.8
Multipurpose 6.2 8.9 4.8 6.9 30.0 2.3
Judkins right 31.0 22.8 33.4 41.4 26.7 16.3
Barbeau 0.4 0.0 0.5 3.4 0.0 0.0
Kimny 0.7 1.3 0.8 0.0 0.0 0.0
Fajadet 0.2 0.0 0.0 0.0 0.0 0.0
Other 4.7 11.4 3.0 0.0 13.3 11.6
Right SVG
Left bypass graft 3.5 3.8 3.1 0.0 0.0 3.5
Amplatz left 20.8 5.1 17.5 41.4 20.0 59.3
Multipurpose 29.2 65.8 30.8 13.8 26.7 4.7
Judkins right 39.6 17.7 41.8 44.8 40.0 20.9
Barbeau 0.9 0.0 1.5 0.0 0.0 0.0
Kimny 0.5 0.0 0.7 0.0 0.0 0.0
Fajadet 0.0 0.0 0.0 0.0 0.0 0.0
Other 5.5 7.6 4.6 0.0 13.3 11.6
Values given are percentages.
Cx circumflex artery; LAD left anterior descending coronary artery; other abbreviations asin Tables 1 and 3.
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1028re the most frequently used. For right bypass graft
CI, the preferred guiding catheters are the Judkins
ight (39.6%), multipurpose (29.2%), and Amplatz left
20.8%).
emostasis and radial occlusion. To obtain hemostasis,
he recently introduced “air-bag”-based bracelet (TR
and, Terumo) is becoming the most frequently used
emostasis device, especially in the U.S. (54.4%) and
apan (69.8%) (Table 5). Nevertheless, simple gauze and
lastic bandage are used in 29.7% of cases, especially in
anada and Europe (31.2%) and India (58.6%). More
han 50% of operators in the U.S., Canada, and Europe
o not routinely assess radial artery patency before
ospital discharge. Most estimate that early RAO occurs
n 5% of cases, although a significant number do not
now, and 10% estimate the incidence of RAO is
etween 5% and 10%. To assess radial artery patency
efore hospital discharge, 50% simply check the pulse
efore hospital discharge. In the U.S., approximately 20%
ill assess RAO incidence with echo-Doppler or oxim-
try/plethysmography testing.
ospital discharge and TRA practice. Same-day home
ischarge or same-day transfer to referring hospitals after
ncomplicated PCI is performed on at least 50% of the
Table 5. Acces-Site Management After PCI
All U.S. Canada-Europe China India Japan
Hemostasis technique
“Air bag”-based bracelet 39.7 54.4 34.8 42.9 34.5 69.8
“Plastic” bracelet 20.6 32.9 24.4 25.0 3.4 5.8
Gauze  bandage 29.7 2.5 31.2 14.3 58.6 7.0
“Plastic”  “elastic” strap 8.1 8.9 7.8 17.9 3.4 12.8
Other 2.0 1.3 1.8 0.0 0.0 4.7
RAO assessment before hospital
discharge
Yes 47.5 48.1 41.0 64.3 58.6 64.0
No 52.5 51.9 59.0 35.7 41.4 36.0
Estimated RAO before hospital
discharge
0% 7.9 8.9 5.5 7.1 17.2 4.7
5% 52.6 45.6 53.1 64.3 44.8 67.4
5%–10% 10.4 7.6 9.6 21.4 17.2 16.3
10% 0.7 0.0 0.7 0.0 0.0 0.0
Unknown 28.3 38.0 31.2 7.1 20.7 11.6
RAO assessment before hospital
discharge
Doppler 7.1 7.6 7.5 14.3 13.8 0.0
Oximetry/plethysmography 5.5 11.4 5.1 3.6 17.2 0.0
Pulse check 55.2 44.3 49.8 71.4 44.8 79.1
None 31.1 36.7 36.3 10.7 20.7 19.8
Other 1.0 0.0 1.3 0.0 3.4 1.2
Values given are percentages.
PCI percutaneous coronary intervention; RAO radial artery occlusion.atients by 13.3% and 24.2% of operators, respectivelyFigs. 4A and 4B). Of note, 52.2% and 45.4% of
perators never discharge patients to home the same day
r transfer them to referring hospitals, respectively.
Overall, approximately 50% of respondents declare that
heir TRA practice will increase in the future (Fig. 5).
his number rises to 68.4% in the U.S., 62.1% in India,
nd 60.7% in China, compared with 43.4% in Canada
nd Europe and 32.6% in Japan.
iscussion
e report the results of the first large international
urvey analyzing the current practice of TRA for coronary
iagnostic angiography and interventions. Our main
ndings can be summarized as follows: 1) TRA is used by
nterventional cardiologists around the world; 2) al-
hough dual hand circulation is assessed in most cases
efore procedure, 23.4% do not perform any pre-test; 3)
n case of first radial access-site failure, 50% of opera-
ors revert to standard FA; 4) diagnostic and PCI
Figure 4. Same-Day Home Discharge or Hospital Transfer After
Percutaneous Coronary Intervention
Proportion of same-day home discharge (A) or hospital transfer (B) in
patients after percutaneous coronary intervention by transradial approach.
Can-Euro  Canada and Europe.
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1029atheters are similar to those used for FA; 5) to prevent
AO, 95% use heparin; 6) for elective PCI and PCI in
CS, the most popular antithrombotic regimen remains
eparin-based; 7) although 50% do not assess RAO
efore hospital discharge, 10% of operators assume that
he incidence of RAO is 5%; and 8) the practice of
ame-day home discharge or transfer to referring centers
emains infrequent after PCI performed by TRA.
espondent characteristics. Age of the operator and
ong-time expertise with FA is often cited as a reason
hy traditionally trained (i.e., FA) operators are not keen
o use TRA (11). In fact, all age categories were repre-
ented in our survey, with approximately 25% of current
RA operators 50 years of age. It is interesting to note
hat there were more high-volume TRA operators per-
orming diagnostic cases than PCI cases. This might
eem at first paradoxical, because primary benefits of
RA are linked to a reduction of bleeding due to
ntithrombotic regimens used for PCI. It might reflect,
owever, that in some cases (i.e., requiring 6-F cathe-
ers) TRA operators still prefer other access site, most
robably standard FA.
atient selection. Since the introduction of TRA, it has
een recommended to assess dual-hand circulation before
se (12). The most popular test remains the Allen test,
hich is easy to use but remains subjective. More-
ver, because this test or the more objective oximetry/
lethysmography tests have not been shown to be pre-
ictive of hand ischemia in case of RAO, some operators
ave questioned the utility of assessing dual-hand circu-
ation (13). Indeed, 23.4% of operators do not assess dual
and circulation at all, and this proportion even reaches
0.8% among operators that use TRA in 50% of their
CI procedures. It remains uncertain whether assessment
Figure 5. Future Practice of TRA
Estimated personal use of transradial approach (TRA) in future practice
compared with current practice. Can-Euro  Canada and Europe.f dual hand circulation before TRA is required. bechnical aspects. Navigation through the brachial and
ubclavian arteries with wires and catheters might some-
imes be technically challenging, due to vessel loops or
ortuosity (14). For diagnostic cases, Judkins left 3.5
most common) and 4.0 and right catheters remain the
ost frequently used catheter shapes. Indeed, although
RA pioneers designed several catheter shapes to can-
ulate LCA and RCA with a single catheter, these
atheters are rarely used. To perform angiography of
aphenous vein grafts, operators also use the same cath-
ters as those used for FA.
For LCA and Cx PCI, the large majority of TRA
perators use extra back-up guiding catheters, although
0% still prefer to use Judkins left. For RCA PCI,
udkins right remains the most popular, probably due to
ts versatility, because it may be intubated into the vessel
o gain additional support if required. For saphenous vein
rafts PCI, TRA operators also use the same guiding
atheters as for FA. Overall, the use of TRA does not
equire using different catheter shapes than for FA (15).
he 5-F catheters have been associated with increased
atient comfort and reduced risk of RAO but remain less
requently used (16). In Japan, TRA operators have
ecently developed miniaturized devices called “slender
ystems” (17,18). Further research will be required to
valuate whether this might be applicable to Caucasian
atients, but obviously TRA is a strong incentive for
evice manufacturers to constantly miniaturize their
roducts.
ntithrombotic strategies. To prevent RAO, heparin has
een recommended even for diagnostic cases (19). With
urrent practice using smaller catheter sizes, aspirin, and
hienopyridines pre-treatment, the direct impact of hep-
rinization on RAO after diagnostic cases remains largely
nknown. For elective cases and ACS, heparin remains
he most popular antithrombotic agent outside the U.S.,
here bivalirudin is used frequently. Further research
ith the use of bivalirudin and TRA is clearly required to
etter define the gain in the reduction of nonaccess site
leeding as well as its impact on RAO (20,21).
emostasis. Completing hemostasis after TRA is rela-
ively simple, because the artery is superficial and easy to
ompress. The concept of patent radial artery hemostasis
as been recently promoted to reduce the incidence of
AO (22). It is somewhat surprising that 50% of TRA
perators do not assess the incidence of RAO before
ospital discharge. Many operators are probably biased,
ecause RAO is most often asymptomatic and frequently
ransient. Because permanent RAO might prevent recur-
ent use of radial artery access, it is probable that this
omplication has been underestimated. With the emer-
ence of reduced or new antithrombotic strategies, it will
e essential to better evaluate the incidence of RAO and
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1030efine means to minimize the risk of post-procedure
AO.
ospital discharge. Because TRA offers rapid hemostasis
nd allows patients to be ambulatory immediately after
ompletion of the procedures, same-day discharge or
ransfer to referring centers of hospitalized patients is
impler than after FA. A few randomized studies have
lso confirmed the safety of outpatient practice after
ncomplicated PCI, even in ACS patients (23–25).
espite proven safety, there might be several negative
ncentives for same-day discharge or transfer, and further
esearch is required to promote outpatient practice.
tudy limitations. This survey provides a snapshot of
ransradial practice around the world and cannot take
nto account changes over time. It is possible that
perators with interest in TRA were more likely to
espond, which could inflate the percentage of procedures
erformed via TRA in this study. Furthermore, it is likely
hat some technical aspects differ significantly between
ontinents. Finally, high-volume transradial operators
an possibly handle technical aspects differently com-
ared with low-volume operators.
onclusions
his survey provides several teaching points with TRA.
oday, TRA is used in a large number of countries for
iagnostic and PCI. Few technical points need to be
earned to practice TRA. Most TRA operators use
tandard diagnostic and guiding catheters initially de-
igned for FA. Therefore, we believe that most PCI
rograms should involve specific TRA training and
xposure. With current devices and practice, TRA could
ecome rapidly the default technique for diagnostic
ngiography and interventions, instead of being reserved
or patients at high risk of bleeding.
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